Postreperfusion syndrome during liver transplantation

Korean Journal of Anesthesiology

Volumn 68, Issue 6, 2015, Pages 527-539

  Jeong, Sung Moon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Hemodynamic disturbance; Liver transplantation; Reperfusion

Indexed keywords

ADRENALIN; BICARBONATE; FRESH FROZEN PLASMA; HYPERTENSIVE AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 2; METHYLENE BLUE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

AIR EMBOLISM; BRADYCARDIA; CENTRAL VENOUS PRESSURE; GRAFT DYSFUNCTION; HEART ARRHYTHMIA; HEART OUTPUT; HEMODYNAMIC MONITORING; HUMAN; HYPERKALEMIA; HYPONATREMIA; LIVER TRANSPLANTATION; LUNG ARTERY PRESSURE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; MORTALITY; PHLEBOTOMY; POSTREPERFUSION SYNDROME; REPERFUSION INJURY; REVIEW; SYNDROME; SYSTEMIC VASCULAR RESISTANCE; VASOPLEGIA;

EID: 84949445835     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2015.68.6.527     Document Type: Review

References (142)

1. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659-76.
2. Starzl TE, Fung JJ. Themes of liver transplantation. Hepatology 2010; 51: 1869-84.
3. Dienstag JL, Cosimi AB. Liver transplantation--a vision realized. N Engl J Med 2012; 367: 1483-5.
4. Calne RY, Rolles K, White DJ, Thiru S, Evans DB, McMaster P, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979; 2: 1033-6.
5. Reich DL, Wood RK Jr, Emre S, Bodian CA, Hossain S, Krol M, et al. Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2003; 17: 699-702.
6. Valentine E, Gregorits M, Gutsche JT, Al-Ghofaily L, Augoustides JG. Clinical update in liver transplantation. J Cardiothorac Vasc Anesth 2013; 27: 809-15.
7. Aggarwal S, Kang Y, Freeman JA, Fortunato FL, Pinsky MR. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 1987; 19(4 Suppl 3): 54-5.
8. Fiegel M, Cheng S, Zimmerman M, Seres T, Weitzel NS. Postreperfusion syndrome during liver transplantation. Semin Cardiothorac Vasc Anesth 2012; 16: 106-13.
9. Paugam-Burtz C, Kavafyan J, Merckx P, Dahmani S, Sommacale D, Ramsay M, et al. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl 2009; 15: 522-9.
10. Hilmi I, Horton CN, Planinsic RM, Sakai T, Nicolau-Raducu R, Damian D, et al. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008; 14: 504-8.
11. Aggarwal S, Kang Y, Freeman JA, Fortunato FL Jr, Pinsky MR. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care 1993; 8: 154-60.
12. Garutti Martinez I, Olmedilla L, Perez-Pena JM, Zaballos M, Sanz J, Vigil MD, et al. Response to clamping of the inferior vena cava as a factor for predicting postreperfusion syndrome during liver transplantation. Anesth Analg 1997; 84: 254-9.
13. Nanashima A, Pillay P, Crawford M, Nakasuji M, Verran DJ, Painter D. Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. J Hepatobiliary Pancreat Surg 2001; 8: 557-63.
14. Chui AK, Shi L, Tanaka K, Rao AR, Wang LS, Bookallil M, et al. Postreperfusion syndrome in orthotopic liver transplantation. Transplant Proc 2000; 32: 2116-7.
15. Fukazawa K, Yamada Y, Gologorsky E, Arheart KL, Pretto EA Jr. Hemodynamic recovery following postreperfusion syndrome in liver transplantation. J Cardiothorac Vasc Anesth 2014; 28: 994-1002.
16. Pan X, Apinyachon W, Xia W, Hong JC, Busuttil RW, Steadman RH, et al. Perioperative complications in liver transplantation using donation after cardiac death grafts: a propensity-matched study. Liver Transpl 2014; 20: 823-30.
17. Xu ZD, Xu HT, Yuan HB, Zhang H, Ji RH, Zou Z, et al. Postreperfusion syndrome during orthotopic liver transplantation: a single-center experience. Hepatobiliary Pancreat Dis Int 2012; 11: 34-9.
18. Bukowicka B, Akar RA, Olszewska A, Smoter P, Krawczyk M. The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. Ann Transplant 2011; 16: 26-30.
19. Ayanoglu HO, Ulukaya S, Tokat Y. Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. Transplant Proc 2003; 35: 1442-4.
20. Chung IS, Kim HY, Shin YH, Ko JS, Gwak MS, Sim WS, et al. Incidence and predictors of post-reperfusion syndrome in living donor liver transplantation. Clin Transplant 2012; 26: 539-43.
21. Abouna GM, Skillen A, Hull CJ, Hodson A, Kirkley JR. A comparison of the effects of warm ischemia and hypothermia on liver glycogen, electrolytes, pH, and subsequent function during perfusion. Br J Surg 1969; 56: 382-3.
22. Chapin JW, Wood RP, Hurlbert BJ, Shaw BW Jr, Kennedy EM, Cuka DJ, et al. Sources of increased serum potassium following reperfusion of liver allografts. Transplant Proc 1987; 19(4 Suppl 3): 51-3.
23. Marino IR, De Luca G. Orthotopic liver transplantation in pigs. An evaluation of different methods of avoiding the revascularization syndrome. Transplantation 1985; 40: 494-8.
24. Blanot S, Gillon MC, Lopez I, Ecoffey C. Circulating endotoxins and postreperfusion syndrome during orthotopic liver transplantation. Transplantation 1995; 60: 103-6.
25. Bezinover D, Kadry Z, Uemura T, Sharghi M, Mastro AM, Sosnoski DM, et al. Association between plasma cyclic guanosine monophosphate levels and hemodynamic instability during liver transplantation. Liver Transpl 2013; 19: 191-8.
26. Ramsay M. The reperfusion syndrome: have we made any progress? Liver Transpl 2008; 14: 412-4.
27. Bezinover D, Kadry Z, McCullough P, McQuillan PM, Uemura T, Welker K, et al. Release of cytokines and hemodynamic instability during the reperfusion of a liver graft. Liver Transpl 2011; 17: 324-30.
28. Maring JK, Klompmaker IJ, Zwaveling JH, van Der Meer J, Limburg PC, Slooff MJ. Endotoxins and cytokines during liver transplantation: changes in plasma levels and effects on clinical outcome. Liver Transpl 2000; 6: 480-8.
29. Ishine N, Yagi T, Ishikawa T, Sasaki H, Nakagawa K, Tanaka N. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation. Transplant Proc 1997; 29: 378-81.
30. Langle F, Roth E, Steininger R, Winkler S, Muhlbacher F. Arginase release following liver reperfusion. Evidence of hemodynamic action of arginase infusions. Transplantation 1995; 59: 1542-9.
31. Moench C, Uhrig A, Lohse AW, Otto G. The role of monocyte chemoattractant protein-1 in orthotopic liver transplantation. Transplant Proc 2003; 35: 1452-5.
32. Enright SM, Srinivasa R, Bellamy MC. Effect of graft reperfusion on intracellular calcium levels in mononuclear leucocytes during human orthotopic liver transplantation. Br J Surg 1998; 85: 673-6.
33. Girn HR, Ahilathirunayagam S, Mavor AI, Homer-Vanniasinkam S. Reperfusion syndrome: cellular mechanisms of microvascular dysfunction and potential therapeutic strategies. Vasc Endovascular Surg 2007; 41: 277-93.
34. Conti A, Scala S, D'Agostino P, Alimenti E, Morelli D, Andria B, et al. Wide gene expression profiling of ischemia-reperfusion injury in human liver transplantation. Liver Transpl 2007; 13: 99-113.
35. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-61.
36. Siniscalchi A, Dante A, Spedicato S, Riganello L, Zanoni A, Cimatti M, et al. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transplant Proc 2010; 42: 1197-9.
37. Huet PM, Nagaoka MR, Desbiens G, Tarrab E, Brault A, Bralet MP, et al. Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. Hepatology 2004; 39: 1110-9.
38. Gu XP, Jiang Y, Xu FT, Qiu YD, Ding YT. Effect of cold-ischemia time on nuclear factor-kappaB activation and inflammatory response in graft after orthotopic liver transplantation in rats. World J Gastroenterol 2004; 10: 1000-4.
39. Selzner N, Selzner M, Tian Y, Kadry Z, Clavien PA. Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: A TNF-alpha/IL-6-dependent mechanism. Hepatology 2002; 36: 812-8.
40. Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg 2006; 243: 748-53.
41. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-59.
42. Totsuka E, Fung JJ, Hakamada K, Ohashi M, Takahashi K, Nakai M, et al. Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation. Transplant Proc 2004; 36: 1955-8.
43. Gruttadauria S, Cintorino D, Musumeci A, Arcadipane A, Burgio G, Clarizia S, et al. Comparison of two different techniques of reperfusion in adult orthotopic liver transplantation. Clin Transplant 2006; 20: 159-62.
44. Moreno C, Sabate A, Figueras J, Camprubi I, Dalmau A, Fabregat J, et al. Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: Influence of hepatic artery or portal vein revascularization of the graft. Liver Transpl 2006; 12: 1607-14.
45. Daniela K, Michael Z, Florian I, Silvia S, Estrella J, Doris D, et al. Influence of retrograde flushing via the caval vein on the post-reperfusion syndrome in liver transplantation. Clin Transplant 2004; 18: 638-41.
46. Millis JM, Melinek J, Csete M, Imagawa DK, Olthoff KM, Neelankanta G, et al. Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation. Transplantation 1997; 63: 397-403.
47. Jugan E, Albaladejo P, Jayais P, Ecoffey C. The failure of venovenous bypass to prevent graft liver postreperfusion syndrome. Transplantation 1992; 54: 81-4.
48. Acosta F, Rodriguez MA, Sansano T, Contreras RF, Reche M, Roques V, et al. Influence of surgical technique on postreperfusion syndrome during liver transplantation. Transplant Proc 1999; 31: 2380-1.
49. Reddy K, Mallett S, Peachey T. Venovenous bypass in orthotopic liver transplantation: time for a rethink? Liver Transpl 2005; 11: 741-9.
50. Neuhaus P, Platz KP. Liver transplantation: newer surgical approaches. Baillieres Clin Gastroenterol 1994; 8: 481-93.
51. Witkowski K, Piecuch J. Liver transplant without a venovenous bypass. Ann Transplant 2001; 6: 16-7.
52. Shaw BW Jr, Martin DJ, Marquez JM, Kang YG, Bugbee AC Jr, Iwatsuki S, et al. Venous bypass in clinical liver transplantation. Ann Surg 1984; 200: 524-34.
53. Riegel W, Spillner G, Schlosser V, Horl WH. Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988; 95: 1014-9.
54. Solberg R, Scholz T, Videm V, Okkenhaug C, Aasen AO. Heparin coating reduces cell activation and mediator release in an in vitro venovenous bypass model for liver transplantation. Transpl Int 1998; 11: 252-8.
55. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989; 210: 649-52.
56. Polak WG, Nemes BA, Miyamoto S, Peeters PM, de Jong KP, Porte RJ, et al. End-to-side caval anastomosis in adult piggyback liver transplantation. Clin Transplant 2006; 20: 609-16.
57. Gong N, Chen X. Partial liver transplantation. Front Med 2011; 5: 1-7.
58. Haberal M, Dalgic A. New concepts in organ transplantation. Transplant Proc 2004; 36: 1219-24.
59. Hall TH, Dhir A. Anesthesia for liver transplantation. Semin Cardiothorac Vasc Anesth 2013; 17: 180-94.
60. Vogt DP, Henderson JM, Carey WD, Barnes D. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002; 132: 775-80.
61. Murray KF, Carithers RL Jr. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology 2005; 41: 1407-32.
62. Da Luz LT, Nascimento B, Shankarakutty AK, Rizoli S, Adhikari NK. Effect of thromboelastography (TEG(R)) and rotational thromboelastometry (ROTEM(R)) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care 2014; 18: 518.
63. Gorlinger K. Coagulation management during liver transplantation. Hamostaseologie 2006; 26(3 Suppl 1): S64-76.
64. Song JG, Jeong SM, Jun IG, Lee HM, Hwang GS. Five-minute parameter of thromboelastometry is sufficient to detect thrombocytopenia and hypofibrinogenaemia in patients undergoing liver transplantation. Br J Anaesth 2014; 112: 290-7.
65. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009; 37: 3124-57.
66. de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ, et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008; 106: 32-44.
67. Boin IF, Leonardi MI, Luzo AC, Cardoso AR, Caruy CA, Leonardi LS. Intraoperative massive transfusion decreases survival after liver transplantation. Transplant Proc 2008; 40: 789-91.
68. Palomo Sanchez JC, Jimenez C, Moreno Gonzalez E, Garcia I, Palma F, Loinaz C, et al. Effects of intraoperative blood transfusion on postoperative complications and survival after orthotopic liver transplantation. Hepatogastroenterology 1998; 45: 1026-33.
69. Pereboom IT, de Boer MT, Haagsma EB, Hendriks HG, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg 2009; 108: 1083-91.
70. Massicotte L, Sassine MP, Lenis S, Seal RF, Roy A. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth 2005; 52: 148-55.
71. Liu LL, Niemann CU. Intraoperative management of liver transplant patients. Transplant Rev (Orlando) 2011; 25: 124-9.
72. Bao FP, Wu J. Continuous versus bolus cardiac output monitoring during orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int 2008; 7: 138-44.
73. Feltracco P, Biancofiore G, Ori C, Saner FH, Della Rocca G. Limits and pitfalls of haemodynamic monitoring systems in liver transplantation surgery. Minerva Anestesiol 2012; 78: 1372-84.
74. Krenn CG, De Wolf AM. Current approach to intraoperative monitoring in liver transplantation. Curr Opin Organ Transplant 2008; 13: 285-90.
75. Burtenshaw AJ, Isaac JL. The role of trans-oesophageal echocardiography for perioperative cardiovascular monitoring during orthotopic liver transplantation. Liver Transpl 2006; 12: 1577-83.
76. Bendjelid K, Romand JA. Fluid responsiveness in mechanically ventilated patients: a review of indices used in intensive care. Intensive Care Med 2003; 29: 352-60.
77. Kumar A, Anel R, Bunnell E, Habet K, Zanotti S, Marshall S, et al. Pulmonary artery occlusion pressure and central venous pressure failto predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med 2004; 32: 691-9.
78. Gwak MS, Kim JA, Kim GS, Choi SJ, Ahn H, Lee JJ, et al. Incidence of severe ventricular arrhythmias during pulmonary artery catheterization in liver allograft recipients. Liver Transpl 2007; 13: 1451-4.
79. Biancofiore G, Critchley LA, Lee A, Bindi L, Bisa M, Esposito M, et al. Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery. Br J Anaesth 2009; 102: 47-54.
80. Biais M, Nouette-Gaulain K, Cottenceau V, Vallet A, Cochard JF, Revel P, et al. Cardiac output measurement in patients undergoing liver transplantation: pulmonary artery catheter versus uncalibrated arterial pressure waveform analysis. Anesth Analg 2008; 106: 1480-6.
81. Rudnick MR, Marchi LD, Plotkin JS. Hemodynamic monitoring during liver transplantation: A state of the art review. World J Hepatol 2015; 7: 1302-11.
82. Michard F, Boussat S, Chemla D, Anguel N, Mercat A, Lecarpentier Y, et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 2000; 162: 134-8.
83. Cannesson M, Musard H, Desebbe O, Boucau C, Simon R, Henaine R, et al. The ability of stroke volume variations obtained with Vigileo/ FloTrac system to monitor fluid responsiveness in mechanically ventilated patients. Anesth Analg 2009; 108: 513-7.
84. Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med 2009; 37: 2642-7.
85. Su BC, Tsai YF, Cheng CW, Yu HP, Yang MW, Lee WC, et al. Stroke volume variation derived by arterial pulse contour analysis is a good indicator for preload estimation during liver transplantation. Transplant Proc 2012; 44: 429-32.
86. Kim SH, Hwang GS, Kim SO, Kim YK. Is stroke volume variation a useful preload index in liver transplant recipients? A retrospective analysis. Int J Med Sci 2013; 10: 751-7.
87. Biais M, Nouette-Gaulain K, Roullet S, Quinart A, Revel P, Sztark F. A comparison of stroke volume variation measured by Vigileo/FloTrac system and aortic Doppler echocardiography. Anesth Analg 2009; 109: 466-9.
88. Hadian M, Severyn DA, Pinsky MR. The effects of vasoactive drugs on pulse pressure and stroke volume variation in postoperative ventilated patients. J Crit Care 2011; 26: 328. e1-8.
89. Soubrier S, Saulnier F, Hubert H, Delour P, Lenci H, Onimus T, et al. Can dynamic indicators help the prediction of fluid responsiveness in spontaneously breathing critically ill patients? Intensive Care Med 2007; 33: 1117-24.
90. De Backer D, Heenen S, Piagnerelli M, Koch M, Vincent JL. Pulse pressure variations to predict fluid responsiveness: influence of tidal volume. Intensive Care Med 2005; 31: 517-23.
91. Reuter DA, Bayerlein J, Goepfert MS, Weis FC, Kilger E, Lamm P, et al. Influence of tidal volume on left ventricular stroke volume variation measured by pulse contour analysis in mechanically ventilated patients. Intensive Care Med 2003; 29: 476-80.
92. Monnet X, Bleibtreu A, Ferre A, Dres M, Gharbi R, Richard C, et al. Passive leg-raising and end-expiratory occlusion tests perform better than pulse pressure variation in patients with low respiratory system compliance. Crit Care Med 2012; 40: 152-7.
93. Guerin L, Monnet X, Teboul JL. Monitoring volume and fluid responsiveness: from static to dynamic indicators. Best Pract Res Clin Anaesthesiol 2013; 27: 177-85.
94. Bottiger BW, Sinner B, Motsch J, Bach A, Bauer H, Martin E. Continuous versus intermittent thermodilution cardiac output measurement during orthotopic liver transplantation. Anaesthesia 1997; 52: 207-14.
95. Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004; 10: 174-82.
96. Ramsay MA, Simpson BR, Nguyen AT, Ramsay KJ, East C, Klintmalm GB. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 1997; 3: 494-500.
97. Kuo PC, Plotkin JS, Gaine S, Schroeder RA, Rustgi VK, Rubin LJ, et al. Portopulmonary hypertension and the liver transplant candidate. Transplantation 1999; 67: 1087-93.
98. Sussman N, Kaza V, Barshes N, Stribling R, Goss J, O'Mahony C, et al. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series. Am J Transplant 2006; 6: 2177-82.
99. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonaryrelated mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6: 443-50.
100. Ramsay M. Portopulmonary hypertension and right heart failure in patients with cirrhosis. Curr Opin Anaesthesiol 2010; 23: 145-50.
101. Safdar Z, Bartolome S, Sussman N. Portopulmonary hypertension: an update. Liver Transpl 2012; 18: 881-91.
102. American Society of A, Society of Cardiovascular Anesthesiologists Task Force on Transesophageal E. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 2010; 112: 1084-96.
103. Markin NW, Sharma A, Grant W, Shillcutt SK. The safety of transesophageal echocardiography in patients undergoing orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2015; 29: 588-93.
104. Burger-Klepp U, Karatosic R, Thum M, Schwarzer R, Fuhrmann V, Hetz H, et al. Transesophageal echocardiography during orthotopic liver transplantation in patients with esophagoastric varices. Transplantation 2012; 94: 192-6.
105. Schumann R, Mandell MS, Mercaldo N, Michaels D, Robertson A, Banerjee A, et al. Anesthesia for liver transplantation in United Statesacademic centers: intraoperative practice. J Clin Anesth 2013; 25: 542-50.
106. Wax DB, Torres A, Scher C, Leibowitz AB. Transesophageal echocardiography utilization in high-volume liver transplantation centers in the United States. J Cardiothorac Vasc Anesth 2008; 22: 811-3.
107. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006; 43(2 Suppl 1): S121-31.
108. Ripoll C, Yotti R, Bermejo J, Banares R. The heart in liver transplantation. J Hepatol 2011; 54: 810-22.
109. Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002; 26: 842-7.
110. Dawwas MF, Lewsey JD, Watson CJ, Gimson AE. The impact of serum potassium concentration on mortality after liver transplantation: a cohort multicenter study. Transplantation 2009; 88: 402-10.
111. Xia VW, Ghobrial RM, Du B, Chen T, Hu KQ, Hiatt JR, et al. Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg 2007; 105: 780-5.
112. Xia VW, Obaidi R, Park C, Braunfeld M, Neelakanta G, Nourmand H, et al. Insulin therapy in divided doses coupled with blood transfusion versus large bolus doses in patients at high risk for hyperkalemia during liver transplantation. J Cardiothorac Vasc Anesth 2010; 24: 80-3.
113. Park C, Hsu C, Neelakanta G, Nourmand H, Braunfeld M, Wray C, et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation 2009; 87: 1031-6.
114. Ammori JB, Sigakis M, Englesbe MJ, O'Reilly M, Pelletier SJ. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res 2007; 140: 227-33.
115. Wallia A, Parikh ND, Molitch ME, Mahler E, Tian L, Huang JJ, et al. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation 2010; 89: 222-6.
116. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-97.
117. Hackworth WA, Heuman DM, Sanyal AJ, Fisher RA, Sterling RK, Luketic VA, et al. Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver Int 2009; 29: 1071-7.
118. Yun BC, Kim WR, Benson JT, Biggins SW, Therneau TM, Kremers WK, et al. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology 2009; 49: 1610-5.
119. Lee EM, Kang JK, Yun SC, Kim KH, Kim SJ, Hwang KS, et al. Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation. Eur Neurol 2009; 62: 362-8.
120. Hudcova J, Ruthazer R, Bonney I, Schumann R. Sodium homeostasis during liver transplantation and correlation with outcomes. Anesth Analg 2014; 119: 1420-8.
121. Ramsay MA, Takaoka F, Brown MR, Rosenlof P. Coronary artery vasospasm following placement of a cold liver graft during orthotopic liver transplantation. Anesth Analg 1989; 69: 854-5.
122. Aufhauser DD Jr, Rose T, Levine M, Barnett R, Ochroch EA, Aukburg S, et al. Cardiac arrest associated with reperfusion of the liver during transplantation: incidence and proposal for a management algorithm. Clin Transplant 2013; 27: 185-92.
123. Williams JW, Vera S, Peters TG, Van Voorst S, Britt LG, Dean PJ, et al. Cholestatic jaundice after hepatic transplantation. A nonimmunologically mediated event. Am J Surg 1986; 151: 65-70.
124. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31: 1752-8.
125. Wagener G, Kovalevskaya G, Minhaz M, Mattis F, Emond JC, Landry DW. Vasopressin deficiency and vasodilatory state in end-stage liver disease. J Cardiothorac Vasc Anesth 2011; 25: 665-70.
126. Roth JV. The use of vasopressin bolus to treat refractory hypotension secondary to reperfusion during orthotopic liver transplantation. Anesth Analg 2006; 103: 261.
127. Oltean M, Herlenius G. Renal protection during liver transplantation: an ounce of prevention is worth a pound of cure. Crit Care Med 2011; 39: 1564-5.
128. Hong SH, Lee JM, Choi JH, Chung HS, Park JH, Park CS. Perioperative assessment of terlipressin infusion during living donor liver transplantation. J Int Med Res 2012; 40: 225-36.
129. Mukhtar A, Salah M, Aboulfetouh F, Obayah G, Samy M, Hassanien A, et al. The use of terlipressin during living donor liver transplantation: Effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med 2011; 39: 1329-34.
130. Riha H, Augoustides JG. Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery. J Cardiothorac Vasc Anesth 2011; 25: 736-8.
131. Fischer GW, Bengtsson Y, Scarola S, Cohen E. Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation. J Cardiothorac Vasc Anesth 2010; 24: 463-6.
132. Cheng SS, Berman GW, Merritt GR, Hendrickse A, Fiegel MJ, Teitelbaum I, et al. The response to methylene blue in patients with severe hypotension during liver transplantation. J Clin Anesth 2012; 24: 324-8.
133. Rosique RG, Rosique MJ, Rosique IA, Tirapelli LF, Castro e Silva O Jr, dos Santos JS, et al. Effect of methylene blue on the hemodynamic instability resulting from liver ischemia and reperfusion in rabbits. Transplant Proc 2011; 43: 3643-51.
134. Fukazawa K, Pretto EA. The effect of methylene blue during orthotopic liver transplantation on post reperfusion syndrome andpostoperative graft function. J Hepatobiliary Pancreat Sci 2011; 18: 406-13.
135. Koelzow H, Gedney JA, Baumann J, Snook NJ, Bellamy MC. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg 2002; 94: 824-9.
136. Daemen-Gubbels CR, Groeneveld PH, Groeneveld AB, van Kamp GJ, Bronsveld W, Thijs LG. Methylene blue increases myocardial function in septic shock. Crit Care Med 1995; 23: 1363-70.
137. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993; 45: 367-74.
138. Mayer B, Brunner F, Schmidt K. Novel actions of methylene blue. Eur Heart J 1993; 14 Suppl I: 22-6.
139. Hori N, Okanoue T, Mori T, Kashima K, Nishimura M, Nanbu A, et al. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis. Clin Exp Pharmacol Physiol 1996; 23: 30-5.
140. Schneider F, Lutun P, Boudjema K, Wolf P, Tempe JD. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology 1994; 19: 38-44.
141. O'Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, Watson AJ. Acute renal disease, as defined by the RIFLE criteria, postliver transplantation. Am J Transplant 2007; 7: 168-76.
142. Wei Y, Zhang L, Lin H, Li J, Li B, Yan L, et al. Factors related to post-liver transplantation acute renal failure. Transplant Proc 2006; 38: 2982-4